|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2003-3-18
|
|
pubmed:abstractText |
Recombinant human vascular endothelial growth factor protein (rhVEGF) stimulates angiogenesis in animal models and was well tolerated in Phase I clinical trials. VIVA (Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis) is a double-blind, placebo-controlled trial designed to evaluate the safety and efficacy of intracoronary and intravenous infusions of rhVEGF.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
pubmed-author:AnnexBrian HBH,
pubmed-author:AzrinMichael AMA,
pubmed-author:BajamondeAlexA,
pubmed-author:BenzaRaymond LRL,
pubmed-author:BermanDaniel SDS,
pubmed-author:FineJenniferJ,
pubmed-author:GibsonC MichaelCM,
pubmed-author:GiordanoFrank JFJ,
pubmed-author:HenryTimothy DTD,
pubmed-author:LopezJohn JJJ,
pubmed-author:McCluskeyEdward RER,
pubmed-author:McKendallGeorge RGR,
pubmed-author:RundleAmy ChenAC,
pubmed-author:ShahP KPK,
pubmed-author:VIVA Investigators,
pubmed-author:WillersonJames TJT
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
18
|
|
pubmed:volume |
107
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1359-65
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12642354-Adult,
pubmed-meshheading:12642354-Aged,
pubmed-meshheading:12642354-Angina Pectoris,
pubmed-meshheading:12642354-Coronary Circulation,
pubmed-meshheading:12642354-Coronary Vessels,
pubmed-meshheading:12642354-Double-Blind Method,
pubmed-meshheading:12642354-Endothelial Growth Factors,
pubmed-meshheading:12642354-Exercise Test,
pubmed-meshheading:12642354-Female,
pubmed-meshheading:12642354-Humans,
pubmed-meshheading:12642354-Infusions, Intravenous,
pubmed-meshheading:12642354-Intercellular Signaling Peptides and Proteins,
pubmed-meshheading:12642354-Lymphokines,
pubmed-meshheading:12642354-Male,
pubmed-meshheading:12642354-Middle Aged,
pubmed-meshheading:12642354-Myocardial Ischemia,
pubmed-meshheading:12642354-Neovascularization, Physiologic,
pubmed-meshheading:12642354-Quality of Life,
pubmed-meshheading:12642354-Recombinant Proteins,
pubmed-meshheading:12642354-Vascular Endothelial Growth Factor A,
pubmed-meshheading:12642354-Vascular Endothelial Growth Factors
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis.
|
|
pubmed:affiliation |
Division of Cardiology at Hennepin County Medical Center and University of Minnesota, Minneapolis, USA. henry003@tc.umn.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
